Durability of the Prostatic Urethral Lift: 2-Year Results of the L.I.F.T. Study

Urology Practice

Volumn 2, Issue 1, 2015, Pages 26-32

  Roehrborn, Claus G ^a   Gange, Steven N ^b   Shore, Neal D ^c   Giddens, Jonathan L ^d   Bolton, Damien M ^e   Cowan, Barrett E ^f   Cantwell, Anthony L ^g   McVary, Kevin T ^h   Te, Alexis E ⁱ   Gholami, Shahram S ^j   Rashid, Prem ^k   Moseley, William G ^l   Chin, Peter T ^m   Dowling, William T ⁿ   Freedman, Sheldon J ^o   Incze, Peter F ^p   Coffield, K Scott ^q   Borges, Fernando D ^r   Rukstalis, Daniel B ^s  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Western Urological Clinic   (United States)

^c Carolina Urologic Research   (United States)

^d Cosmetic Surgery Hospital ^*  (Canada)

^e AUSTIN HOSPITAL   (Australia)

^f Urology Associates   (United States)

^g Atlantic Urological Associates   (United States)

^h SOUTHERN ILLINOIS UNIVERSITY   (United States)

ⁱ WEILL CORNELL MEDICAL CENTER   (United States)

^j Pediatric Orthopaedics Associates of Silicon Valley   (United States)

^k PORT MACQUARIE BASE HOSPITAL   (Australia)

^l SD Uro Research   (United States)

^m Figtree Private Hospital   (Australia)

ⁿ Chesapeake Urology Associates   (United States)

^o Sheldon J Freedman MD Ltd   (United States)

^p Oakville Trafalgar Memorial Hospital   (Canada)

^q SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^r Pinellas Urology   (United States)

^s WAKE FOREST UNIVERSITY   (United States)

more..

Author keywords

Benign prostatic hyperplasia; Minimally invasive surgical procedures; Prostate; Prostheses and implants; Urethra

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; DOUBLE BLIND PROCEDURE; DYSURIA; FOLLOW UP; HEMATURIA; HUMAN; IMPLANT; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE PROCEDURE; MULTICENTER STUDY; PELVIC PAIN; PROSTATIC URETHRAL LIFT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; TREATMENT OUTCOME; URGE INCONTINENCE; URINARY URGENCY; URINE FLOW RATE;

EID: 84927669371     PISSN: 23520779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urpr.2014.08.001     Document Type: Article

References (29)

1. Roehrborn C.G. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol 2008, 10:14.
2. Verhamme K.M., Dieleman J.P., Bieumink G.S., et al. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph Project. Eur Urol 2003, 58:539.
3. Roehrborn C.G., McConnell J.D., Bary M.J., et al. American Urological Association Guideline: management of benign prostatic hyperplasia (BPH). Linthicum, Maryland: American Urological Association Education and Research, Inc. 2003.
4. McVary K.T., Roehrborn C.G., Avins A.L., et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011, 185:1793.
5. Thangasamy I.A., Chalasani V., Bachmann A., et al. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012, 62:315.
6. Bouza C., Lopez T., Magro A., et al. Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol 2006, 6:14.
7. Hoffman R.M., Monga M., Elliott S.P., et al. Microwave thermotherapy forbenign prostatic hyperplasia. Cochrane Database Syst Rev 2012, 9:CD004135.
8. Shore N., Freedman S., Gange S., et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 2014, 21:7094.
9. Cantwell A.L., Bogache W.K., Richardson S.F., et al. Multi-center prospective crossover study of the prostatic urethral lift for the treatment of LUTS secondary to BPH. BJU Int 2013, 113:615.
10. McVary K.T., Gange S.N., Shore N.D., et al. Treatment of LUTS secondary toBPH while preserving sexual function: randomized controlled study of the prostatic urethral lift. JSex Med 2014, 11:279.
11. Roehrborn C.G., Gange S.N., Shore N.D., et al. Multi-center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study. JUrol 2013, 190:2162.
12. McNicholas T.A., Woo H.H., Chin P.T., et al. Minimally invasive prostatic urethral lift: surgical technique and multinational study. Eur Urol 2013, 64:292.
13. Chin P.T., Bolton D.M., Rashid J.G., et al. Prostatic urethral lift: two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology 2012, 79:5.
14. Woo H.H., Chin P.T., McNicholas T.A., et al. Safety and feasibility of theprostatic urethral lift: a novel minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hypertrophy (BPH). BJU Int 2011, 108:82.
15. Grino P., Bruskewitz R., Blaivis J., et al. Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. JUrol 1993, 149:339.
16. Roos N.P., Wennberg J.E., Malenka D.J., et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. NEngl J Med 1989, 320:1120.
17. Madersbacher S., Lackner J., Brossner C., et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: anation-wide long-term analysis of 23,123 cases. Eur Urol 2005, 47:499.
18. Mamoulakis C., Schulze M., Skolarikos A., et al. Midterm results from aninternational multicentre randomised controlled trial comparing bipolarwith monopolar transurethral resection of the prostate. Eur Urol 2013, 63:667.
19. Tabatabaei S., Choi B., Collins E., et al. 120W Greenlight laser prostatectomy-one year data from an ongoing prospective multicentre study (International Greenlight Users Group-IGLU). JUrol 2010, 184:e740. abstract 1904.
20. Bouchier-Hayes D.M., Anderson P., Van Appledorn S., et al. KTP laser versus transurethral resection: early results of a randomized trial. JEndourol 2006, 20:580.
21. Tasci A.I., Ilbey Y., Luleci H., et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 2011, 78:134.
22. Ruszat R., Seitz M., Wyler S.F., et al. GreenLight laser vaporization oftheprostate: single-center experience and long-term results after 500procedures. Eur Urol 2008, 54:893.
23. Ruszat R., Wyler S.F., Seitz M., et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008, 102:1432.
24. Rieken M., Ebinger Mundorff N., Bonkat G., et al. Complications oflaser prostatectomy: a review of recent data. World J Urol 2010, 28:53.
25. Alivizatos G., Skolarikos A., Chalikopoulos D., et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas > 80ml: 12-mo results of a randomized prospective study. Eur Urol 2008, 54:427.
26. Horasanli K., Silay M.S., Altay B., et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of theprostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008, 71:247.
27. Hai M.A. Photoselective vaporization of the prostate: five-year outcomes of entire clinic patient population. Urology 2009, 73:807.
28. Al-Ansari A., Younes N., Sampige V.P., et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010, 58:349.
29. Broggi E., May A., Giretti G., et al. Long-term outcomes of 80-Watt KTP and 120-Watt HPS GreenLight photoselective vaporization of the prostate. Urol Int 2014, 93:229.